{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:56:35Z","timestamp":1792040195295,"version":"4.4.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T00:00:00Z","timestamp":1658966400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"NINDS","doi-asserted-by":"publisher","award":["R01NS073613"],"award-info":[{"award-number":["R01NS073613"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroscience Methods"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jneumeth.2022.109679","type":"journal-article","created":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T07:38:32Z","timestamp":1659166712000},"page":"109679","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Validation of DREADD agonists and administration route in a murine model of sleep enhancement"],"prefix":"10.1016","volume":"380","author":[{"given":"Loris L.","family":"Ferrari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oghomwen E.","family":"Ogbeide-Latario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinrich S.","family":"Gompf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Anaclet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneumeth.2022.109679_bib1","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.1523\/JNEUROSCI.2955-17.2018","article-title":"Genetic activation, inactivation, and deletion reveal a limited and nuanced role for somatostatin-containing basal forebrain neurons in behavioral state control","volume":"38","author":"Anaclet","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneumeth.2022.109679_bib2","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/nn.3789","article-title":"The GABAergic parafacial zone is a medullary slow wave sleep-promoting center","volume":"17","author":"Anaclet","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jneumeth.2022.109679_bib3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/npp.2017.152","article-title":"Activation of the GABAergic parafacial zone maintains sleep and counteracts the wake-promoting action of the psychostimulants armodafinil and caffeine","volume":"43","author":"Anaclet","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jneumeth.2022.109679_bib4","doi-asserted-by":"crossref","first-page":"8744","DOI":"10.1038\/ncomms9744","article-title":"Basal forebrain control of wakefulness and cortical rhythms","volume":"6","author":"Anaclet","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jneumeth.2022.109679_bib5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3389\/fnins.2019.00187","article-title":"The chemogenetic receptor ligand clozapine N-oxide induces in vivo neuroreceptor occupancy and reduces striatal glutamate levels","volume":"13","author":"Baerentzen","year":"2019","journal-title":"Front Neurosci."},{"key":"10.1016\/j.jneumeth.2022.109679_bib6","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3389\/fnins.2019.00755","article-title":"Differential role of pontomedullary glutamatergic neuronal populations in sleep-wake control","volume":"13","author":"Erickson","year":"2019","journal-title":"Front Neurosci."},{"issue":"29","key":"10.1016\/j.jneumeth.2022.109679_bib7","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1523\/JNEUROSCI.0325-22.2022","article-title":"Resting-state fMRI-based screening of deschloroclozapine in rhesus macaques predicts dosage-dependent behavioral effects","volume":"42","author":"Fujimoto","year":"2022","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneumeth.2022.109679_bib8","first-page":"406","article-title":"How genetically engineered systems are helping to define, and in some cases redefine, the neurobiological basis of sleep and wake","volume":"2","author":"Fuller","year":"2015","journal-title":"Temp. (Austin)"},{"key":"10.1016\/j.jneumeth.2022.109679_bib9","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.1038\/s41598-019-41088-2","article-title":"Pharmacokinetic and pharmacodynamic actions of clozapine-N-oxide, clozapine, and compound 21 in DREADD-based chemogenetics in mice","volume":"9","author":"Jendryka","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jneumeth.2022.109679_bib10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrneurol.2013.269","article-title":"Sleep and Alzheimer disease pathology--a bidirectional relationship","volume":"10","author":"Ju","year":"2014","journal-title":"Nat. Rev. Neurol."},{"issue":"5","key":"10.1016\/j.jneumeth.2022.109679_bib11","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0219-16.2016","article-title":"Clozapine N-oxide administration produces behavioral effects in long-evans rats: implications for designing DREADD experiments","volume":"3","author":"MacLaren","year":"2016","journal-title":"eNeuro"},{"key":"10.1016\/j.jneumeth.2022.109679_bib12","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/npp.2017.299","article-title":"CNO Evil? considerations for the use of DREADDs in behavioral neuroscience","volume":"43","author":"Mahler","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.jneumeth.2022.109679_bib13","doi-asserted-by":"crossref","first-page":"zsz302","DOI":"10.1093\/sleep\/zsz302","article-title":"Dual orexin receptor antagonists increase sleep and cataplexy in wild type mice","volume":"43","author":"Mahoney","year":"2019","journal-title":"Sleep"},{"key":"10.1016\/j.jneumeth.2022.109679_bib14","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/s41593-020-0661-3","article-title":"Deschloroclozapine, a potent and selective chemogenetic actuator enables rapid neuronal and behavioral modulations in mice and monkeys","volume":"23","author":"Nagai","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jneumeth.2022.109679_bib15","doi-asserted-by":"crossref","first-page":"6595","DOI":"10.1038\/s41598-022-10668-0","article-title":"Behavioral and slice electrophysiological assessment of DREADD ligand, deschloroclozapine (DCZ) in rats","volume":"12","author":"Nentwig","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jneumeth.2022.109679_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/sleepadvances\/zpac022","article-title":"Two novel mouse models of slow-wave-sleep enhancement in aging and Alzheimer\u2019s disease","volume":"3","author":"Ogbeide-Latario","year":"2022","journal-title":"Sleep. Adv."},{"key":"10.1016\/j.jneumeth.2022.109679_bib17","series-title":"The Mouse Brain In Stereotaxic Coordinates","author":"Paxinos","year":"2001"},{"key":"10.1016\/j.jneumeth.2022.109679_bib18","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.neuron.2016.01.040","article-title":"DREADDs for neuroscientists","volume":"89","author":"Roth","year":"2016","journal-title":"Neuron"},{"issue":"14","key":"10.1016\/j.jneumeth.2022.109679_bib19","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1021\/acschemneuro.2c00304","article-title":"Evidence that GIRK channels mediate the DREADD-hM4Di receptor activation-induced reduction in membrane excitability of striatal medium spiny neurons","volume":"13","author":"Shan","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.jneumeth.2022.109679_bib20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1037\/bne0000433","article-title":"Dreadds: Use and application in behavioral neuroscience","volume":"135","author":"Smith","year":"2021","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.jneumeth.2022.109679_bib21","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.ymthe.2021.11.019","article-title":"Chemogenetics as a neuromodulatory approach to treating neuropsychiatric diseases and disorders","volume":"30","author":"Song","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jneumeth.2022.109679_bib22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1021\/acsptsci.8b00012","article-title":"DREADD agonist 21 is an effective agonist for muscarinic-based DREADDs in vitro and in vivo","volume":"1","author":"Thompson","year":"2018","journal-title":"ACS Pharm. Transl. Sci."},{"key":"10.1016\/j.jneumeth.2022.109679_bib23","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1038\/s41467-020-17197-2","article-title":"Suprachiasmatic VIP neurons are required for normal circadian rhythmicity and comprised of molecularly distinct subpopulations","volume":"11","author":"Todd","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jneumeth.2022.109679_bib24","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/j.cub.2016.05.078","article-title":"A novel population of wake-promoting GABAergic neurons in the ventral lateral hypothalamus","volume":"26","author":"Venner","year":"2016","journal-title":"Curr. Biol."},{"key":"10.1016\/j.jneumeth.2022.109679_bib25","doi-asserted-by":"crossref","first-page":"8929","DOI":"10.1523\/JNEUROSCI.1032-19.2019","article-title":"Reassessing the role of histaminergic tuberomammillary neurons in arousal control","volume":"39","author":"Venner","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneumeth.2022.109679_bib26","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41386-019-0478-5","article-title":"Bidirectional relationship between sleep and Alzheimer's disease: role of amyloid, tau, and other factors","volume":"45","author":"Wang","year":"2020","journal-title":"Neuropsychopharmacology"}],"container-title":["Journal of Neuroscience Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165027022002060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165027022002060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:02:21Z","timestamp":1759021341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165027022002060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":26,"alternative-id":["S0165027022002060"],"URL":"https:\/\/doi.org\/10.1016\/j.jneumeth.2022.109679","relation":{},"ISSN":["0165-0270"],"issn-type":[{"value":"0165-0270","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of DREADD agonists and administration route in a murine model of sleep enhancement","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroscience Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneumeth.2022.109679","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109679"}}